60 DEGREES PHARMACEUTICALS, INC. cotiza a 0.90 USD y tiene una capitalización bursátil de $3M. En los últimos 12 meses ha facturado $1M con un margen de flujo de caja libre del -695.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-1.28 | $-8.17 | $-2.53 | $-4.33 |
| Estimado | $-1.55 | $-2.00 | $-1.84 | $-4.96 |
| Sorpresa | +17.4% | -308.5% | -37.5% | +12.7% |
| Métrica | SXTP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 22.3% | 57.0% | -34.8% |
| Operating Margin | -771.6% | -38.6% | -733.0% |
| Net Margin | -732.5% | -33.6% | -699.0% |
| FCF Margin | -695.1% | -13.9% | -681.2% |
| ROE | -212.7% | -40.4% | -172.3% |
| ROA | -137.3% | -32.0% | -105.2% |
| Current Ratio | 2.66 | 2.84 | -0.18 |
| Debt / Equity | 0.04 | 0.28 | -0.24 |